Anti-cancer MUC1-specific Immunotherapy for Unresectable Stage III Non-small Cell Lung Cancer

Clinical trial NCT01731587 · WITHDRAWN

Trial details

NCT number: NCT01731587
Sponsor: Merck KGaA, Darmstadt, Germany
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC) Stage III

Start date: 2001-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.